EUVIMEDEUVIMED entdecken
Kohortenstudie

Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses Vs Continuous Infusion in Diabetic Patients with Septic Shock: A Prospective Cohort Study

Swathy K, Naveen J, Vivek P, Akhilesh VU, Rathenmurugan Mithun, Sreenath Sreelekshmi, Sudhakaran PR, Oommen V Oommen

Global Journal of Critical Care and Emergency Medicine · 2024

DOI: 10.33425/3065-5641.1008 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Global Journal of Critical Care and Emergency Medicine, 2024. Verfasst von Swathy K und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Objectives: Septic shock is a serious condition associated with a high mortality rate because of the multiorgan dysfunction caused by dysregulated host immune responses to infection. Giving low dose steroids in septic shock patients has been shown to hasten the reversal of shock and current Surviving Sepsis Guidelines (SSG) also suggest using low dose steroids for the same. Also, the use of steroids causes hyperglycaemia particularly in diabetic patients. The current SSG does not specify the method of administration. The primary objective of our study was to compare continuous infusion vs intermittent boluses of hydrocortisone to obtain a better glycaemic control.

Methods

A prospective cohort study was conducted in diabetic patients with septic shock admitted in Multi Disciplinary Intensive Care Unit (MDICU) of PRS hospital from July 2022 to February2023. Hydrocortisone was given as continuous infusion in 55 subjects and the remaining 55 received intermittent boluses of hydrocortisone and average blood glucose values were measured in both the groups.

Results

Among 110 patients, 55 patients each received continuous infusion and intermittent boluses of hydrocortisone respectively. The mean blood glucose values in continuous infusion group were 161.1 ± 22.7 and 172.5 ± 21.0 (mg/ dl) in intermittent boluses group which was statistically significant with a p value of 0.007. There was no statistically significant difference among the groups in 28-day mortality, ICU length of stay (LOS), hospital LOS, or other secondary safety outcomes.

Conclusions

This study infers that giving hydrocortisone as continuous infusions in septic shock patients leads to better glycaemic control when compared to intermittent boluses of hydrocortisone, without any difference in 28-day mortality.

Zitieren

APA

K, S., J, N., P, V., VU, A., Mithun, R., Sreelekshmi, S., PR, S., & Oommen, O. V. (2024). Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses Vs Continuous Infusion in Diabetic Patients with Septic Shock: A Prospective Cohort Study. Global Journal of Critical Care and Emergency Medicine. https://doi.org/10.33425/3065-5641.1008

Vancouver

K S, J N, P V, VU A, Mithun R, Sreelekshmi S, et al. Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses Vs Continuous Infusion in Diabetic Patients with Septic Shock: A Prospective Cohort Study. Global Journal of Critical Care and Emergency Medicine. 2024. doi:10.33425/3065-5641.1008

BibTeX
@article{K2024,
  author = {K, Swathy and J, Naveen and P, Vivek and VU, Akhilesh and Mithun, Rathenmurugan and Sreelekshmi, Sreenath and PR, Sudhakaran and Oommen, Oommen V},
  title = {Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses Vs Continuous Infusion in Diabetic Patients with Septic Shock: A Prospective Cohort Study},
  journal = {Global Journal of Critical Care and Emergency Medicine},
  year = {2024},
  doi = {10.33425/3065-5641.1008}
}
Kostenlos starten →